IN2014DN09216A - - Google Patents

Download PDF

Info

Publication number
IN2014DN09216A
IN2014DN09216A IN9216DEN2014A IN2014DN09216A IN 2014DN09216 A IN2014DN09216 A IN 2014DN09216A IN 9216DEN2014 A IN9216DEN2014 A IN 9216DEN2014A IN 2014DN09216 A IN2014DN09216 A IN 2014DN09216A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Jean-Marie Saint-Remy
Original Assignee
Imnate Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imnate Sarl filed Critical Imnate Sarl
Publication of IN2014DN09216A publication Critical patent/IN2014DN09216A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/37Factors VIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/20Ingredients acting on or related to the structure
    • A23V2200/218Coagulant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0413Blood
    • A61M2202/0445Proteins
    • A61M2202/0447Glycoproteins
    • A61M2202/0452Factor VIII

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN9216DEN2014 2012-05-22 2014-11-03 IN2014DN09216A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12168800.6A EP2666782A1 (fr) 2012-05-22 2012-05-22 Facteur VIII de coagulation avec immunogénicité réduite
PCT/EP2013/060397 WO2013174805A1 (fr) 2012-05-22 2013-05-21 Facteur viii de coagulation ayant une immunogénicité réduite

Publications (1)

Publication Number Publication Date
IN2014DN09216A true IN2014DN09216A (fr) 2015-07-10

Family

ID=48485166

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9216DEN2014 IN2014DN09216A (fr) 2012-05-22 2014-11-03

Country Status (12)

Country Link
US (1) US10087233B2 (fr)
EP (2) EP2666782A1 (fr)
JP (1) JP6363996B2 (fr)
AU (1) AU2013265400B2 (fr)
BR (1) BR112014028575B1 (fr)
CA (1) CA2872938C (fr)
DK (1) DK2852609T3 (fr)
ES (1) ES2751361T3 (fr)
HK (1) HK1203981A1 (fr)
IN (1) IN2014DN09216A (fr)
RU (1) RU2631801C2 (fr)
WO (1) WO2013174805A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3388447A1 (fr) 2017-04-14 2018-10-17 Imnate Sarl Procédés de production de peptides, polypeptides ou cellules pour moduler l'immunité
EP3936867A1 (fr) 2020-07-06 2022-01-12 Imnate Sarl Utilisation d'un epitope-peptide de cd1 dans le traitement d'une maladie causée par un pathogène intracellulaire

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7084251B1 (en) * 1987-02-12 2006-08-01 Genentech, Inc. Methods and Deoxyribonucleic acid for the preparation of tissue factor protein
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
EP0716703A1 (fr) * 1993-09-03 1996-06-19 PRENDERGAST, Kenneth, Francis Compositions proteiques de fusion contenant la proteine de liaison a la glycophorine (gbp 130)
US6458563B1 (en) * 1996-06-26 2002-10-01 Emory University Modified factor VIII
BR0308860A (pt) * 2002-04-18 2005-01-04 Merck Patent Gmbh Fator viii modificado
SI3130601T1 (sl) 2004-11-12 2020-11-30 Bayer Healthcare Llc Usmerjena modifikacija FVIII
WO2006103298A2 (fr) * 2005-04-01 2006-10-05 Novo Nordisk Health Care Ag Analogues du fviii de coagulation sanguine
US20090110861A1 (en) 2007-10-29 2009-04-30 3M Innovative Properties Company Pressure sensitive adhesive article
CN101965409A (zh) * 2007-11-01 2011-02-02 罗切斯特大学 具有增加的稳定性的重组因子viii
EP3075391A1 (fr) 2008-02-14 2016-10-05 Life Sciences Research Partners VZW Stratégies de prévention et/ou de traitement des réponses immunitaires à des facteurs allogènes solubles
EP2149603A1 (fr) * 2008-07-28 2010-02-03 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Variantes du facteur IX dotées d'activité de coagulation en l'absence de leur cofacteur et leur utilisation pour le traitement de troubles du sang
US8691211B2 (en) * 2009-03-10 2014-04-08 Puget Sound Blood Center Suppression of immune response to factor VIII in hemophilia A patients
WO2011060372A2 (fr) * 2009-11-13 2011-05-19 Puget Sound Blood Center Variants d'épitopes des lymphocytes t du facteur viii à immunogénicité réduite
RU2598247C2 (ru) * 2010-11-25 2016-09-20 Имнейт Сарл Изменение иммуногенности антигена путем устранения эпитопов, узнаваемых nkt-клетками

Also Published As

Publication number Publication date
US20150087593A1 (en) 2015-03-26
BR112014028575A2 (pt) 2017-08-01
CA2872938A1 (fr) 2013-11-28
RU2014151719A (ru) 2016-07-10
EP2666782A1 (fr) 2013-11-27
RU2631801C2 (ru) 2017-09-26
BR112014028575B1 (pt) 2022-08-30
JP2015518844A (ja) 2015-07-06
WO2013174805A1 (fr) 2013-11-28
AU2013265400B2 (en) 2017-07-27
HK1203981A1 (en) 2015-11-06
JP6363996B2 (ja) 2018-07-25
EP2852609B1 (fr) 2019-10-09
DK2852609T3 (da) 2019-11-25
CA2872938C (fr) 2020-06-16
EP2852609A1 (fr) 2015-04-01
ES2751361T3 (es) 2020-03-31
AU2013265400A1 (en) 2014-11-13
US10087233B2 (en) 2018-10-02

Similar Documents

Publication Publication Date Title
BR112015001845A2 (fr)
BR112014019260A2 (fr)
BR112014017592A2 (fr)
BR112014017659A2 (fr)
BR112014019065A2 (fr)
AR092201A1 (fr)
BR112014019847A2 (fr)
BR112014017607A2 (fr)
BR112015012963A2 (fr)
BR112014019467A2 (fr)
BR112014019408A2 (fr)
BR112013027865A2 (fr)
BR112014017647A2 (fr)
BR112014017588A2 (fr)
BR112014013184A8 (fr)
BR112014017652A2 (fr)
BR112014017730A2 (fr)
BR112014018263A2 (fr)
BR112014019299A2 (fr)
BR112014017667A2 (fr)
BR112014017600A2 (fr)
BR112014019894A2 (fr)
BR112014017671A2 (fr)
BR112014017596A2 (fr)
BR112014017591A2 (fr)